Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 17
SponsorDana-Farber Cancer Institute
About this trial
The goal of this study is to test if the addition of a novel income-poverty targeted supportive care intervention (Pediatric Resource Intervention to Support Equity \[Pediatric RISE\]) to usual supportive care for low-income children with high-risk neuroblastoma can improve parent- and child-centered outcomes.
Participants will be randomized to receive one of the following for 6-months:
* Usual supportive care alone or * Usual supportive care plus Pediatric RISE
Eligibility criteria
Qualifiers
Patient newly diagnosed with high-risk neuroblastoma
Patient has established care at study site and initiated cancer-directed therapy
Patient has not yet initiated Induction Cycle 3
Patient aged 0-17 years at the time of consent
Disqualifiers
Foreign national family receiving care as an Embassy-pay patient.
Child or household member receiving SSI
Trial design
Treatments tested in this trial
- RISE Intervention
Treatment groups
84 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov